Sleep Disorder Market size to surpass $73.5Bn by 2032

Sleep Disorder Market size is slated to  exceed USD 73.5 billion by 2032, as per a new research report announced by Global Market Insights Inc.
 

The increasing need for efficient, portable, and superior sleep disorder equipment is estimated to drive industry trends. The adoption rate of innovative therapeutic devices is rapidly increasing due to the various benefits associated with them. To cater to this booming demand, prominent market participants are investing in the fabrication of more efficient and superior devices, thereby enhancing segment expansion.
 

Government campaigns to raise treatment awareness to complement insomnia segment

Insomnia causes substantial medical and financial burdens, and its frequency is rising globally. According to the American Academy of Sleep Medicine, over 30% of Americans suffer symptoms of insomnia, and approximately 10% have severe insomnia. leading to daytime implications. Furthermore, to raise awareness about sleep disorders and their treatments, government officials are launching public education programs and clinician training, which are expected to contribute to segment growth by 2032.
 

Browse key industry insights spread across 250 pages with 614 market data tables & 15 figures & charts from the report, “Sleep Disorder Market Size By Disorder (Sleep Apnea {Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea}, Restless Legs Syndrome (RLS), Insomnia, Narcolepsy), By Product (Diagnostics {Actigraphy Systems, Polysomnography (PSG) Device, Respiratory Polygraph, Sleep Screening Devices, Pulse Oximeter, Wearables [Smart Watches & Bands]}, Therapeutics {Cognitive Behavioral Therapy, Therapeutic Devices {Airway Clearance System, Adaptive Servo-ventilation (ASV), Positive Airway Pressure (PAP) Devices, Oral Appliances, Oxygen Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/sleep-disorder-market
 

Increasing awareness of product benefits to impel diagnostics segment

 Sleep disorder market value from the diagnostics product segment is poised to hit USD 50 billion by 2032. The segment expansion is driven by the surging awareness about the product's extensive benefits in the diagnosis of many sleep problems, such as treatment efficacy evaluation, exact disease diagnosis, and so on. Major industry participants are concentrating on developing diagnostic methods and portable diagnostic technologies that are more accessible and less expensive, which is foreseen to positively influence segment outlook  by 2032. Recently, in February 2023, Healthpoint, a Mubadala Health partner, debuted a new diagnostic process in the UAE to effectively treat individuals with obstructive sleep apnea. 
 

Rising preference for sleep labs for quality treatment to fuel sleep laboratories & hospitals segment

 Sleep disorder market from the sleep laboratories & hospitals segment is projected to  cross over USD 30 billion by 2032 due to an increase in patient preference for sleep labs and hospitals for quality sleep disorders treatment. Additionally, the increasing number of sleep laboratories providing high-quality services for the treatment of a wide variety of sleep apnea and related co-morbidities while combining sophisticated equipment catering to the patient population to stimulate segment progress through 2032.
 

Increasing venture capital investments to propel Asia Pacific industry

Asia Pacific sleep disorder market is likely to grow at 13.5% CAGR by 2032. Supportive government programs and increased infusion of venture capital in China and India's healthcare sectors for improvement in the treatment and management of sleep disorders are some of the major factors boosting business landscape. Additionally, efforts by private organizations to increase public awareness about sleep diseases and associated treatments are anticipated to impel APAC industry revenue growth through 2032.
 

Innovative product launches to define the industry

Natus Medical Inc., Fisher & Paykel Healthcare, Koninklijke Philips N.V., Invacare Corporation, Teleflex Inc., and ResMed Inc., are some of the prominent enterprises operating in the sleep disorder industry.